yego.me
💡 Stop wasting time. Read Youtube instead of watch. Download Chrome Extension

The Challenges with Cancer Trials | Breakthrough


2m read
·Nov 11, 2024

ANDRE CHOULIKA: We didn't have any intention of injecting these type of vials to patient because we needed a lot of vials to be able to file our clinical trial application. And this was planned to be done with the University College London.

NARRATOR: Before any new medication or therapy is considered safe and effective, it must first be rigorously tested through clinical trials. These trials are fundamental in determining an experimental treatment's dosage and safety and to identify any possible side effects. At the University College London, Great Ormond Street Institute of Child Health, Professor Waseem Qasim was working with Cellectis as the principal investigator, taking the universal CAR T-cells from the lab to trials.

Normally, this process can take over a decade, with nearly endless layers of approval. So our questions were what do you do if your patient is already so unwell that you can't collect cells; or has had so much chemotherapy that there's no white blood cells left to collect, that you think are going to be useful; how do you do this process in a way that can be done quickly and delivered back to the patient in a timely manner?

And the answer to that is perhaps being able to use a product, a cell product, that's been made beforehand, that can be given back to multiple patients. Now in order to do that, we have to overcome the barrier of transplantation, which means if I put my cells into a nonmatched individual, the cells firstly will want to react against that individual because they will know the individuals is foreign. And secondly, the person receiving the cells will try and reject them because they know the cells are not their own.

NARRATOR: In affiliation with Professor Qasim, Doctor Paul Veys works on the front line with patients who desperately need new cancer treatment options. I'll have treated well over 3,000 patients and at least 600 of those will have gone wrong. So there's a lot of patients that we lose. It's unsuccessful. You've got to be able to come in the next day. Even from our failures, we've learned lots. And if we hadn't gone through those failures, we wouldn't be having some of the successes we have today.

Has the chest always been good? He's not had any big chest infections? NURSE: No. It's not good. Let's warm it up. Sit forward again. Yeah. Perfect. OK. Big breaths.

More Articles

View All
Squishy Robot Fingers: A Breakthrough for Underwater Science | National Geographic
We’re in the northern part of the Red Sea, and the reason we’re here is we’re trying to test out our squishy robot fingers for the first time in a reef. So we tested these squishy fingers in a swimming pool, and now we wanted to put them to the true test…
The Power of 'No'
It’s a short simple word: ‘no’. But for some people, it’s extremely difficult to use nonetheless. Especially so-called ‘people pleasers’ have difficulties saying ‘no’ to the people they intend to please. Which is a shame, because the ability to say ‘no’ …
Why the Stock Market Might Not Crash...
So I like to think I make pretty down-to-earth investing videos. I generally try and avoid speculation, I avoid trendy stocks, I avoid hype, and instead, I just focus on rational thinking and rational investment. That has led, you know, to a fair bit of c…
Peter Lynch: How to Invest Like a Pro (Most Recent Interview)
Now when somebody reports earnings, it’s telecast all over the world. They have an investor presentation; they show a balance sheet. So information is much better. So theoretically, the individual’s edge has improved in the last 23 years versus the profes…
Nietzsche - You Are Your Own Worst Enemy
In Thus Spoke Zarathustra, Friedrich Nietzsche said, “You yourself will always be the worst enemy you can encounter; you yourself lie in wait for yourself in caves and forests.” In my opinion, Nietzsche shared an important insight with us: we really are o…
Khan Academy Ed Talks with Fenesha Hubbard - Thursday, September 2
Hello and welcome to Ed Talks with Khan Academy! I am excited today to be talking to Phoenicia Hubbard, who is with NWEA, one of our partner organizations that we’ll talk more about in a minute. She is the Professional Learning Design Coordinator, so I’m …